CA
NZ
UK
AU
IND
US
BioAffinity Technologies, Inc. has raised approximately $3.6 million through a private placement that includes the issuance of pre-funded warrants and common stock. This move significantly enhances the company'sLiquidityposition, providing resources essential for future operational initiatives. The successful closing of this placement on August 14, …
Aptevo Therapeutics Inc. (NASDAQ: APVO) reported compelling clinical data for its lead candidate mipletamig, demonstrating an 87% clinical benefit rate among frontline acute myeloid leukemia (AML) patients. The performance highlights mipletamig's potential effectiveness when combined with existing treatments, reinforcing Aptevo's strategic focus on improving …
Assembly Biosciences, Inc. (NASDAQ: ASMB) has successfully secured $115 million in gross financing, aCapitalinfusion that directly bolsters itsBalance Sheetand expands the runway for itsDrug Developmentactivities. By adding this financing to an existing cash pool of $320.4 million, the company has effectively increased its liquidity …
Allarity Therapeutics, Inc. (NASDAQ: ALLR) concluded the second quarter of 2026 with a solid cash position of $26.9 million, comprising both cash and restricted cash. This figure represents a substantial increase from the previous year's cash total of $14.7 million, enhancing the company's ability …
AnaptysBio (NASDAQ: ANAB) is a clinical‑stage biotechnology firm with aMarket Capitalisationof $1.73 billion, 29,030,784 shares outstanding and $248.47 million in cash. The company reported trailing‑twelve‑month revenue of $232.39 million, a 107.7% increase year‑over‑year, but posted a net margin of -11.5% and aReturn on Equityof …
Achieve Life Sciences, Inc. (NASDAQ: ACHV) has established an at-the-market (ATM) offering program allowing the sale of common stock worth up to $150 million. This initiative was formalized in an agreement with Jefferies LLC and empowers the company to issue shares as needed through …
Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) has secured approval from NYSE Regulation for a compliance plan through November 27, 2027, allowing its stock to remain actively traded on the NYSE American. The extension follows a prior notice indicating that Actinium did not meet certain …
Smart Powerr Corp. (OTC: CREG) experienced a major shift in leadership on August 13, 2026, with several high-profile resignations that could impact its operational strategy. The company saw the departure of its Chief Financial Officer, Jackie Shi, as well as the resignation of board …
StoneBridge Acquisition II Corp (NASDAQ: APACR) has implemented a significant financial change by waiving a $10,000 monthly fee previously owed to Scieniti LLC. This arrangement was part of an Administrative Services Agreement signed on September 30, 2025, focusing on administrative support and office-related expenses. …
Wheels Up Experience Inc. (NYSE: UP) has announced a significant leadership change as Chief Sales Officer Mark Briffa will depart the role, effective September 1, 2026. He will remain with the company during the transition period to assist in the orderly transfer of his …
Please wait processing your request...